Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportNeurosciences Track

How flexible is [18F]florbetaben (FBB) amyloid PET imaging regarding scan start time?

Henryk Barthel, Aleksandar Jovalekic, Santi Bullich, Susan De Santi, Norman Koglin, Andrew Stephens, Stefan Dresel, Peter Bartenstein, John Seibyl and Osama Sabri
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 555;
Henryk Barthel
9University Hospital Leipzig Leipzig Germany
10University Hospital Leipzig Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aleksandar Jovalekic
5Piramal Imaging Berlin Germany
6Piramal Imaging Berlin Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Santi Bullich
1Igualada (Barcelona) Spain
5Piramal Imaging Berlin Germany
6Piramal Imaging Berlin Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan De Santi
7Piramal Imaging New York NY United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norman Koglin
5Piramal Imaging Berlin Germany
6Piramal Imaging Berlin Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew Stephens
8Piramal Imaging GmbH Berlin Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stefan Dresel
2Helios Hospital Berlin-Buch Berlin Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Bartenstein
4Klinik und Polik.inik fur Nuklearmedizin Munchen Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John Seibyl
3Inst. for Neurodegenerative Disorders New Haven CT United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osama Sabri
9University Hospital Leipzig Leipzig Germany
10University Hospital Leipzig Leipzig Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

555

Objectives: [18F]florbetaben (FBB) is approved in the EU, the USA, Japan and South Korea for clinical use to measure beta-amyloid plaque density in adult patients with cognitive impairment, and is currently employed in the IDEAS trial and other research studies. Depending on the marketing authorizations, different PET acquisition time windows are possible. In a phase 2A study, the accuracy of an expert visual read for earlier acquired PET images (45-60min p.i.) did not differ compared to later acquired PET images (90-110min p.i. and 110-130min p.i.). This present project aimed at further investigating the diagnostic properties of earlier FBB images as analysed in a relative quantitative fashion.

Methods: The FBB Phase 2A study was carried out in 18 centres on 3 continents. The present analysis examined the FBB PET data of 77 patients with probable Alzheimer’s dementia (AD, age 55 years or older, MMSE=18-26, CDR=0.5-2.0) and of 69 age-matched healthy controls (HCs, MMSE 蠅28, CDR=0). Volumes of interest (modified AAL template, PMOD) were defined at the imaging core lab to calculate neocortical composite SUV ratios (cSUVRs) using the cerebellar cortex as the reference region. Clinical diagnosis with its known limitations despite thorough neuropsychiatric examination served as the standard of truth given that histopathological assessment was not available for these subjects.

Results: cSUVRs were significantly higher for the AD patients vs. HCs in all three time-windows (p<0.0001, Cohen’s effect sizes=1.54, 1.37, and 1.44). Receiver-operating characteristics curves resulted in cSUVR thresholds which separated the subject groups with sensitivities/specificities of 79%/93%, 73%/96%, and 75%/91% for the three time-windows. For the AD patients, the binary cSUVR readouts at 45-60min p.i. showed 86% and 88% concordance with those of the 90-110min p.i. and 110-130min p.i. images, respectively. For the HCs, the concordance was 99% and 97%, respectively.

Conclusion: Diagnostic accuracy is not compromised when analysing FBB PET data at the 45-60min time-window in a relative quantitative manner. Further research will address the diagnostic accuracy at this time-window when the PET data are visually analysed by trained non-experts. Research Support: Piramal Imaging, Berlin, Germany

Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
How flexible is [18F]florbetaben (FBB) amyloid PET imaging regarding scan start time?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
How flexible is [18F]florbetaben (FBB) amyloid PET imaging regarding scan start time?
Henryk Barthel, Aleksandar Jovalekic, Santi Bullich, Susan De Santi, Norman Koglin, Andrew Stephens, Stefan Dresel, Peter Bartenstein, John Seibyl, Osama Sabri
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 555;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
How flexible is [18F]florbetaben (FBB) amyloid PET imaging regarding scan start time?
Henryk Barthel, Aleksandar Jovalekic, Santi Bullich, Susan De Santi, Norman Koglin, Andrew Stephens, Stefan Dresel, Peter Bartenstein, John Seibyl, Osama Sabri
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 555;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Neurosciences Track

  • Impact of cognitive reserve in frontotemporal dementia illustrated by FDG-PET.
  • Quantification of brain cholinergic denervation in dementia with Lewy bodies using PET imaging with 18F-FEOBV
  • Kinetic evaluation of [18F]MOZAT PET imaging in humans.
Show more Neurosciences Track

Amyloid Imaging Goes Clinical

  • Impact of florbetaben PET imaging on diagnosis and management of patients with suspected Alzheimer’s Disease eligible for CSF analysis in France
  • Assessing the natural history of Aß-amyloid deposition with five different amyloid tracers using the Centiloid transformation
Show more Amyloid Imaging Goes Clinical

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire